SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-22-000022
Filing Date
2022-01-10
Accepted
2022-01-10 16:32:25
Documents
14
Period of Report
2022-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k.htm   iXBRL 8-K 23362
2 FORM 8-K ex99x1.htm EX-99.1 16523
3 GRAPHIC image_001.jpg GRAPHIC 5237
  Complete submission text file 0001079973-22-000022.txt   224860

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE opgn-20220110.xsd EX-101.SCH 3027
5 XBRL LABEL FILE opgn-20220110_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE opgn-20220110_pre.xml EX-101.PRE 22591
8 EXTRACTED XBRL INSTANCE DOCUMENT opgen_8k_htm.xml XML 3565
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 22521640
SIC: 8071 Services-Medical Laboratories